Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Kim, Orchard"'
Autor:
Robert Torrance, Kim Orchard, Dimitra Peppa, Helena Arellano-Ballestero, Agnieszka Zubiak, Chris Dally, Aljawharah Alrubayyi, Xenia Charalambous, Melina Michael, Trinity Eales, Kushal Das, Maxine G. B. Tran, May Sabry, Mark W. Lowdell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Human and mouse natural killer (NK) cells have been shown to develop memory-like function after short-term exposure to the cocktail of IL-12/15/18 or to overnight co-culture with some tumor cell lines. The resulting cells retain enhanced l
Externí odkaz:
https://doaj.org/article/c2c7715cfa204d06820282339a193374
Autor:
Gavin Giovannoni, Stephen J Walters, David Paling, Olga Ciccarelli, Cindy Cooper, Eli Silber, Martin Duddy, Hannah Hunter, David Hunt, Basil Sharrack, Paul Gallagher, Ian Galea, Richard Nicholas, Annalena Venneri, Neil Robertson, Carolyn Young, Jeremy Hobart, David Rog, Ben Turner, Muhammad Saif, Azza Ismail, Gavin Brittain, John A Snowden, Diana Papaioannou, Alasdair J Coles, Gordon Mazibrada, Neil Scolding, Maruthi Vinjam, Matthew Bursnall, Claire Rice, Ian Pomeroy, Majid Kazmi, Esmaeil Nikfekr, Kim Orchard, Thushan de Silva, Jennifer Petrie, Elisa Roldan, Caroline Besley, Kate E M Duffy, Rachel Glover, Katie Hullock, Colette Beecher, Ian Gabriel, Charalampia Kyriakou, Andy Peniket, Paolo A Muraro, Amy Publicover, Andy Clark, Charles Crawley, Eleni Tholouli, Fran Kinsella, Gabriele De Luca, Jeff Davies, Jenny Byrne, Keith Campbell, Leonora Finisku, Simon Bulley, Vic Campbell
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction Autologous haematopoietic stem cell transplantation (aHSCT) is increasingly used as treatment for patients with active multiple sclerosis (MS), typically after failure of disease-modifying therapies (DMTs). A recent phase III trial, ‘M
Externí odkaz:
https://doaj.org/article/cef35258b9e74bbbaf15d925d8681e1d
Autor:
Toby A. Eyre, Sally F. Barrington, Jessica Okosun, Clementina Abamba, Rachel M. Pearce, Julia Lee, Ben Carpenter, Charles R. Crawley, Adrian J.C. Bloor, Maria Gilleece, Emma Nicholson, Nimish Shah, Kim Orchard, Ram Malladi, William M. Townsend
Publikováno v:
Haematologica, Vol 108, Iss 3 (2022)
The optimum management approach for patients with relapsed or refractory follicular lymphoma remains uncertain. Autologous stem cell transplantation (autoSCT) is considered a standard option in suitable, younger patients with relapsed follicular lymp
Externí odkaz:
https://doaj.org/article/c09e9d9ca56542648022789e4beb2ceb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amal Alseraihy, Eoin McGrath, Dietger Niederwieser, Christian Chabannon, Jeff Szer, Mohamad Mohty, Mohamed A. Kharfan-Dabaja, Kim Orchard, Joseph Schwartz, Walid Rasheed, Mickey Koh, Nicolaus Kröger, Yoshihisa Kodera, Riad El Fakih, Nina Worel, Lynn Manson, Tuula Rintala, Abdelghani Tabakhi, Bipin Savani, Usama Gergis, Anna Sureda, Paul W. Eldridge, Ibrahim Yakoub‐Agha, Mehdi Hamadani, Daniel Weisdorf, Hildegard Greinix, Mahmoud Aljurf
Publikováno v:
Transplantation and Cellular Therapy. 28:455-462
Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complications and, consequently, increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::851e051f1e5b1e3a64f48d18e3cd5623
https://doi.org/10.1016/j.jtct.2022.04.003
https://doi.org/10.1016/j.jtct.2022.04.003
Autor:
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Neil K. Rabin, Anne Marie Stoppa, Ellen Meijer, Jean-Baptiste Mear, Sacha Zeerleder, Jiri Mayer, Roland Fenk, Nathalie Fegueux, Patrice Chevallier, Eva Konirova, John A. Snowden, Monika Engelhardt, Kim Orchard, Cyrille Hulin, Nicolaas Schaap, Claudia Sossa, Ahmet Elmaagacli, Donal P. McLornan, Patrick J. Hayden, Stefan Schönland, Ibrahim Yakoub-Agha
Publikováno v:
Bone Marrow Transplantation. Nature Publishing Group
Beksac, M, Iacobelli, S, Koster, L, Cornelissen, J, Griskevicius, L, Rabin, N K, Stoppa, A M, Meijer, E, Mear, J-B, Zeerleder, S, Mayer, J, Fenk, R, Fegueux, N, Chevallier, P, Konirova, E, Snowden, J A, Engelhardt, M, Orchard, K, Hulin, C, Schaap, N, Sossa, C, Elmaagacli, A, McLornan, D P, Hayden, P J, Schönland, S & Yakoub-Agha, I 2023, ' An early post-transplant relapse prediction score in multiple myeloma : a large cohort study from the chronic malignancies working party of EBMT ', Bone Marrow Transplantation . https://doi.org/10.1038/s41409-023-01999-1
Beksac, M, Iacobelli, S, Koster, L, Cornelissen, J, Griskevicius, L, Rabin, N K, Stoppa, A M, Meijer, E, Mear, J-B, Zeerleder, S, Mayer, J, Fenk, R, Fegueux, N, Chevallier, P, Konirova, E, Snowden, J A, Engelhardt, M, Orchard, K, Hulin, C, Schaap, N, Sossa, C, Elmaagacli, A, McLornan, D P, Hayden, P J, Schönland, S & Yakoub-Agha, I 2023, ' An early post-transplant relapse prediction score in multiple myeloma : a large cohort study from the chronic malignancies working party of EBMT ', Bone Marrow Transplantation . https://doi.org/10.1038/s41409-023-01999-1
Early relapse (ER) following Autologous Hematopoietic Cell Transplantation (AHCT) confers a poor prognosis. We therefore developed a novel scoring system to predict ER. A total of 14,367 AHCT-1 patients were transplanted between 2014 and 2019, and we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43fb4c1e1c34a89ee68a56aa14fdcf34
https://pure.eur.nl/en/publications/a0b2dfef-0ebe-45fa-8fa3-a0858599ba8f
https://pure.eur.nl/en/publications/a0b2dfef-0ebe-45fa-8fa3-a0858599ba8f
Autor:
Jesus Duque-Afonso, Jürgen Finke, Myriam Labopin, Charles Craddock, Rachel Protheroe, Panagiotis Kottaridis, Eleni Tholouli, Jenny L. Byrne, Kim Orchard, Urpu Salmenniemi, Inken Hilgendorf, Hannah Hunter, Emma Nicholson, Adrian Bloor, John A. Snowden, Mareike Verbeek, Andrew Clark, Bipin N. Savani, Alexandros Spyridonidis, Arnon Nagler, Mohamad Mohty
Publikováno v:
Bone Marrow Transplantation. 57:1269-1276
In recent years considerable variations in conditioning protocols for allogeneic hematopoietic cell transplantation (allo-HCT) protocols have been introduced for higher efficacy, lower toxicity, and better outcomes. To overcome the limitations of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b66692c0c7ca15db2feecd745a664d62
https://doi.org/10.1038/s41409-022-01646-1
https://doi.org/10.1038/s41409-022-01646-1
Autor:
Riccardo Saccardi, Hein Putter, Dirk-Jan Eikema, María Paula Busto, Eoin McGrath, Bas Middelkoop, Gillian Adams, Marina Atlija, Francis Ayuketang Ayuk, Helen Baldomero, Yves Beguin, Rafael de la Cámara, Ángel Cedillo, Anna María Sureda Balari, Christian Chabannon, Selim Corbacioglu, Harry Dolstra, Rafael F. Duarte, Rémy Dulery, Raffaella Greco, Andreu Gusi, Nada Hamad, Michelle Kenyon, Nicolaus Kröger, Myriam Labopin, Julia Lee, Per Ljungman, Lynn Manson, Florence Mensil, Noel Milpied, Mohamad Mohty, Elena Oldani, Kim Orchard, Jakob Passweg, Rachel Pearce, Régis Peffault de Latour, Hélène A. Poirel, Tuula Rintala, J. Douglas Rizzo, Annalisa Ruggeri, Carla Sanchez-Martinez, Fermin Sanchez-Guijo, Isabel Sánchez-Ortega, Marie Trnková, David Valcárcel Ferreiras, Leonie Wilcox, Liesbeth C. de Wreede, John A. Snowden
Publikováno v:
Bone Marrow Transplantation, 58, 659-666
Bone Marrow Transplantation, 58, 6, pp. 659-666
Bone Marrow Transplantation, 58, 6, pp. 659-666
Contains fulltext : 293484.pdf (Publisher’s version ) (Open Access) From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b83d9778d232bf48a295ee0ab2e4b76
http://hdl.handle.net/2066/293484
http://hdl.handle.net/2066/293484
Autor:
Joshua Alexander, Fein, Roni, Shouval, Jacques-Emmanuel, Galimard, Myriam, Labopin, Gerard, Socié, Jürgen, Finke, Jan J, Cornelissen, Ram, Malladi, Maija, Itälä-Remes, Patrice, Chevallier, Kim, Orchard, Donald, Bunjes, Mahmoud, Aljurf, Marie-Thérèse, Rubio, Jurjen, Versluis, Mohamad, Mohty, Arnon, Nagler
Publikováno v:
Blood advances.
Older age and high burden of comorbidities often drive selection of low-intensity conditioning regimens in allogeneic-hematopoietic stem cell transplantation (HSCT) recipients. However, the impact of comorbidities in the low-intensity conditioning se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a410ac1a097e1d018b467ffb99e60fa
https://pubmed.ncbi.nlm.nih.gov/36622338
https://pubmed.ncbi.nlm.nih.gov/36622338
Autor:
Eleni Tholouli, Ben Carpenter, Kirsty Thomson, Sara Lozano, Antonio Pagliuca, Adrian Bloor, Amy Publicover, Anne Parker, Gerardo Errico, Kim Orchard, Anjum Khan, Varun Mehra, Karl S. Peggs, Maria A V Marzolini, Emma Nicholson, Jennifer Pirrie, Nick Duncan, Philip Crea, Erin Hurst, John A. Snowden, Jennifer Byrne, Richard Lovell, Maria H. Gilleece
Publikováno v:
Blood Advances
Decreased cytomegalovirus (CMV)-specific immunity after hematopoietic cell transplantation (HCT) is associated with late CMV reactivation and increased mortality. Whether letermovir prophylaxis-associated reduction in viral exposure influences CMV-sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d90182d1314b1af29aaf0a861282702c
https://doi.org/10.1182/bloodadvances.2021005637
https://doi.org/10.1182/bloodadvances.2021005637